Pharma news
Americas
J&J’s Abiomed can proceed with its non-infringement defence despite potential future appellate reversal, in a week when both parties in the case were dealt wins and losses in their clash over Impella devices. 5 May 2026
Europe
John Ward, vice president and associate general counsel of trademarks at Moderna, chats with Tom Phillips at INTA 2026. 5 May 2026
Pharma
The Supreme Court's first look at the skinny label dispute dug into key questions, from the role of the skinny label to who Hikma’s statements were really meant for, in one of the most important patent cases in years. 30 April 2026
Europe
The company’s rivals convinced an EPO appeals board to revoke a patent that had been used in litigation against them over Comirnaty. 30 April 2026
Americas
An event for IP, legal and compliance leaders to address the growing threat of trade secret misappropriation heads to San Jose. 28 April 2026
Europe
An opinion has put pressure on the CJEU to clarify a long-running grey area that could change the game for how drug makers secure supplementary protection certificates across Europe. 24 April 2026
Americas
The US pharma giant is spending up to $1 billion to build an end-to-end biosimilar platform and is counting on a decade of expiring biologic patents to make it pay off. 23 April 2026
Americas
Decision underscores a growing deference to parallel rulings and tighter control over duplicate patent challenges. 22 April 2026
Pharma
The Danish pharma giant is turning to artificial intelligence as it faces patent expiry, falling shares and intensifying competition from Eli Lilly. 15 April 2026
Americas
The 2026 panel has been chosen. With judges from Amgen, Pfizer, Eli Lilly, Takeda, Regeneron and law firms such as White & Case and Arnold & Porter, here’s who will be deciding this year’s winners. 10 April 2026